IL1B and Sepsis: Early repetitive or chronic RIC administration has shown benefits in reducing levels of inflammatory cytokines (such as TNF-α, IL-1β, and IL-6) following lipopolysaccharide-induced sepsis and has been associated with a reduction in mortality in mice [17].